Odyssey HealthCare to Present at Merrill Lynch Health Services Investor Conference
Posted on: Wednesday, 21 November 2007, 12:01 CST
Odyssey HealthCare, Inc. (NASDAQ:ODSY), today announced that it will deliver a presentation at the Merrill Lynch Health Services Investor Conference on Wednesday, November 28, 2007, at 1:45 p.m. Eastern Time at the Merrill Lynch Headquarters in New York City.
To access a live broadcast of Odyssey's presentation, listeners should go to the Investor Relations section of the Company's website, www.odsyhealth.com. For those unable to hear the live broadcast, a 14-day replay will be available after the presentation until December 12, 2007.
Based in Dallas, Texas, Odyssey is one of the largest providers of hospice care in the country in terms of both average daily patient census and number of locations. Odyssey seeks to improve the quality of life of terminally ill patients and their families by providing care directed at managing pain and other discomforting symptoms and by addressing the psychosocial and spiritual needs of patients and their families.
Certain statements that will be contained in the presentation are forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements are based on management's current expectations and are subject to known and unknown risks, uncertainties and assumptions which may cause the forward-looking events and circumstances discussed in the presentation to differ materially from those anticipated or implied by the forward-looking statements
. Such risks, uncertainties and assumptions include, but are not limited to, general market conditions; adverse changes in reimbursement levels under Medicare and Medicaid programs; adverse changes in the Medicare payment cap limits and increases in the Company's estimated Medicare cap contractual adjustment; decline in patient census growth; increases in inflation including inflationary increases in patient care costs; challenges inherent in and potential changes in the Company's growth and development strategy; our ability to effectively implement the Company's 2007 operations and development initiatives; the Company's dependence on patient referral sources and potential adverse changes in patient referral practices of those referral sources; our ability to implement a new integrated billing and clinical management and electronic medical records system; the ability to attract and retain healthcare professionals; increases in the Company's bad debt expense due to various factors including an increase in the volume of pre-payment reviews by the Company's Medicare fiscal intermediaries; adverse changes in the state and federal licensure and certification laws and regulations; adverse results of regulatory surveys; delays in licensure and/or certification; government and private party, legal proceedings and investigations; cost of complying with the terms and conditions of our corporate integrity agreement; adverse changes in the competitive environment in which the Company operates; changes in state or federal income, franchise or similar tax laws and regulations; adverse impact of natural disasters; changes in our estimate of additional compensation costs under FASB Statement No. 123(R); and the disclosures contained under the headings "Government Regulation and Payment Structure" in "Item 1. Business" and "Item 1A. Risk Factors" of Odyssey's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 9, 2007, and its most recent report on Form 10-Q and in its other filings with the Securities and Exchange Commission. Many of these factors are beyond the ability of the Company to control or predict. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements, which reflect management's views only as of the date hereof. The Company undertakes no obligation to revise or update any of the forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements.Source: Business Wire
Related Articles
- 1 In 4 Hospitalized Heart Failure Patients With Medicare Back In Hospital Within A Month
- Independence Blue Cross Set to Present on Patient Safety Strategies for Lower Costs, Healthier Outcomes at PA Nurses Summit
- Parkinson's Disease Alters Patient's Ability to Learn from Rewards
- QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients
- Credit Scoring Limitations: nTelagent's New Predictive Modeling for Assessing Patients' Ability to Pay Can Help Healthcare Providers Manage Self-Pay Accounts, Rising Bad Debt
- General Satisfaction With Plan Benefits Found Among Patients Navigating Medicare Part D, According to Study By GfK Market Measures
- SCHEDULE CHANGE: Pharmos Corporation to Present at BMO Capital Markets Focus on Healthcare Conference at 10:30 AM Eastern Time on December 7, 2006
- Advanced Spinal Technologies, Inc. Presents Positive Patient Treatment Results to the American Academy of Orthopedic Manual Physical Therapists (AAOMPT)
- Per-Se Technologies Helps Hospitals Forecast Patients' Ability to Pay for Care With Patient Verification Services 4.1 Release; New Software Release Improves Efficiency of Revenue Cycle
- InforMedix CEO Presents at Patient Safety Conference ``New Technology and the Prevention of Errors''
User Comments (0)

RSS Feeds